Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Denali Therapeutics Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
DNLI
Nasdaq
2836
https://www.denalitherapeutics.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Denali Therapeutics Inc
Denali (DNLI) Q1 Earnings Miss, Pipeline Progress in Focus
- May 8th, 2024 12:20 pm
Denali Therapeutics Q1 2024 Earnings: Misses Revenue Estimates Amid Strategic Shifts
- May 7th, 2024 9:56 pm
Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
- May 7th, 2024 8:01 pm
Denali Therapeutics Announces Completion of Enrollment for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial
- May 1st, 2024 12:00 pm
Is There An Opportunity With Denali Therapeutics Inc.'s (NASDAQ:DNLI) 50% Undervaluation?
- Apr 29th, 2024 11:34 am
Why Denali Therapeutics (DNLI) Stock Might be a Great Pick
- Apr 9th, 2024 12:46 pm
Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report: Can It Continue?
- Mar 29th, 2024 3:30 pm
Why Is Denali Therapeutics (DNLI) Up 2.8% Since Last Earnings Report?
- Mar 28th, 2024 3:30 pm
Further weakness as Denali Therapeutics (NASDAQ:DNLI) drops 7.4% this week, taking three-year losses to 67%
- Mar 19th, 2024 10:30 am
Denali's (DNLI) Q4 Earnings Miss, Pipeline in Focus, Stock Up
- Feb 28th, 2024 1:08 pm
Denali Therapeutics Inc (DNLI) Reports Full Year and Q4 2023 Financial Results
- Feb 27th, 2024 1:31 pm
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
- Feb 27th, 2024 1:05 pm
Denali Therapeutics Announces $500 million Private Placement Equity Financing
- Feb 27th, 2024 1:00 pm
Denali, fresh off study setback, gets $500M lift
- Feb 27th, 2024 11:53 am
UPDATE 2-Denali-Sanofi's ALS drug fails to meet mid-stage trial goal
- Feb 16th, 2024 1:39 pm
ALS drug from Denali, Sanofi falls short in mid-stage study
- Feb 16th, 2024 12:13 pm
Denali Therapeutics Announces New Data and Expansion of Its Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapy Programs at WORLDSymposiumâ„¢
- Feb 7th, 2024 1:00 pm
Denali Therapeutics Announces Presentations on Its Investigational Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapies at the Upcoming 2024 WORLDSymposiumâ„¢
- Feb 1st, 2024 1:00 pm
Denali's (DNLI) Pipeline Progresses Despite Stiff Competition
- Jan 26th, 2024 3:00 pm
40 Cities with the Lowest Life Expectancy in the US
- Jan 11th, 2024 6:11 pm
Scroll